(Q30582000)

25 June 2017

1 reference

title

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation (English)

1 reference

25 June 2017

0 references

0 references

1 reference

Markku Partinen

15

0 references

Teresa Paiva

object named as

Teresa Paiva

14

0 references

Giuseppe Plazzi

object named as

Giuseppe Plazzi

4

0 references

Jan Bonhoeffer

21

object named as

Jan Bonhoeffer

1 reference

25 June 2017

2

Sebastiaan Overeem

1 reference

25 June 2017

3

Gert Jan Lammers

1 reference

25 June 2017

7

Yves Dauvilliers

1 reference

25 June 2017

12

Hanna Nohynek

1 reference

25 June 2017

18

Miriam Sturkenboom

1 reference

25 June 2017

6

Claudio L Bassetti

1 reference

25 June 2017

5

Michel Lecendreux

1 reference

25 June 2017

9

Ramin Khatami

1 reference

25 June 2017

16

Thomas E Scammell

1 reference

25 June 2017

17

Tom Shimabukuro

1 reference

25 June 2017

1

Francesca Poli

1 reference

25 June 2017

Daniel Keene

8

1 reference

25 June 2017

Yulin Li

10

1 reference

25 June 2017

Geert Mayer

11

1 reference

25 June 2017

Barbara Pahud

13

1 reference

25 June 2017

Kristy van Dinther

19

1 reference

25 June 2017

Max Wiznitzer

20

1 reference

25 June 2017

language of work or name

English

0 references

publication date

16 December 2012

1 reference

25 June 2017

1 reference

25 June 2017

volume

31

1 reference

25 June 2017

issue

6

1 reference

25 June 2017

page(s)

994-1007

1 reference

The clinical spectrum of narcolepsy with cataplexy: a reappraisal.

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy-cataplexy associated with precocious puberty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Current evaluation and management of excessive daytime sleepiness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The clinical features of cataplexy: A questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Multiple sclerosis presenting as catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Cataplexy associated with midbrain lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Symptomatic cataplexy in pontomedullary lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Continuous cataplexy in a patient with a midbrain tumor: The limp man syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Niemann-Pick disease type C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

"Cataplexy" and muscle ultrasound abnormalities in Coffin-Lowry syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Cataplexy in association with Moebius syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Genetic factors in human sleep disorders with special reference to Norrie disease, Prader-Willi syndrome and Moebius syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Cataplexy and monoamine oxidase deficiency in Norrie disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep disorders in Wilson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin (orexin) deficiency in human narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

CSF hypocretin-1 assessment in sleep and neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin deficiency in Prader-Willi syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Low levels of ventricular CSF orexin/hypocretin in advanced PD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin (orexin) loss in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The epidemiology of narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy in the older adult: epidemiology, diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Age at onset of narcolepsy in two large populations of patients in France and Quebec.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Factors associated with a delay in the diagnosis of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy in prepubertal children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Cataplexy features in childhood narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Reduced number of hypocretin neurons in human narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy: a review of evidence for autoimmune diathesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy: immunological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy is strongly associated with the T-cell receptor alpha locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Common variants in P2RY11 are associated with narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The clinical spectrum of narcolepsy and idiopathic hypersomnia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep Disorders Classification Committee, Association of Sleep Disorders Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Post-H1N1 narcolepsy-cataplexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy with cataplexy associated with H1N1 vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

NOCTURNAL SLEEP OF NARCOLEPTICS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

REM sleep episodes during the multiple sleep latency test in narcoleptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Diagnosis of narcolepsy using the multiple sleep latency test: analysis of current laboratory criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The Multiple Sleep Latency Test: a paradoxical test?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Assessment: techniques associated with the diagnosis and management of sleep disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The positive diagnosis of narcolepsy and narcolepsy's borderland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Effect of age on MSLT results in patients with narcolepsy-cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The clinical use of the MSLT and MWT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The narcoleptic borderland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Pseudocataplexy: gelastic-atonic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus ("limp man syndrome").

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Reevaluating spells initially identified as cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Status cataplecticus misdiagnosed as recurrent syncope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Pseudocataplexy in narcolepsy with cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Pseudocataplexy and transient functional paralysis: a spectrum of psychogenic motor disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

A video-polygraphic analysis of the cataplectic attack.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Effects of startle and laughter in cataplectic subjects: a neurophysiological study between attacks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Behavioural and neurophysiological correlates of human cataplexy: a video-polygraphic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Diagnosing narcolepsy: validity and reliability of new diagnostic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Diagnosing narcolepsy with cataplexy on history alone: challenging the International Classification of Sleep Disorders (ICSD-2) criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Social and emotional aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

7 January 2021

Narcolepsy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Nocturnal aspects of narcolepsy with cataplexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

[Evaluation of excessive daytime sleepiness in child and adolescent psychopathology].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep disorders in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep disorders in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Sleep and sleep disorders in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy and other hypersomnias in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The clinical and laboratory assessment of the sleepy child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

[Narcolepsy with cataplexy in the child: clinical evaluation and therapeutical management].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy in children: a single-center clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Psychosocial and intellectual functioning in childhood narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Pubertal changes in daytime sleepiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The influence of age and sex on sleep latency in the MSLT-30--a normative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Narcolepsy with cataplexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Genetics of narcolepsy and other sleep disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.12.014

1 reference

25 June 2017

1 reference